243 related articles for article (PubMed ID: 25743259)
1. Interleukin-10 Induces Both Plasma Cell Proliferation and Angiogenesis in Multiple Myeloma.
Alexandrakis MG; Goulidaki N; Pappa CA; Boula A; Psarakis F; Neonakis I; Tsirakis G
Pathol Oncol Res; 2015 Sep; 21(4):929-34. PubMed ID: 25743259
[TBL] [Abstract][Full Text] [Related]
2. Emerging roles of endoglin/CD105 and angiogenic cytokines for disease development and progression in multiple myeloma patients.
Pappa CA; Alexandrakis MG; Boula A; Psarakis FE; Kolovou A; Bantouna V; Stavroulaki E; Tsirakis G
Hematol Oncol; 2013 Dec; 31(4):201-5. PubMed ID: 23576184
[TBL] [Abstract][Full Text] [Related]
3. Circulating angiogenic cytokines in multiple myeloma and related disorders.
Urba ska-Rys H; Wierzbowska A; Robak T
Eur Cytokine Netw; 2003; 14(1):40-51. PubMed ID: 12799213
[TBL] [Abstract][Full Text] [Related]
4. Angiogenic factors in multiple myeloma: higher levels in bone marrow than in peripheral blood.
Di Raimondo F; Azzaro MP; Palumbo G; Bagnato S; Giustolisi G; Floridia P; Sortino G; Giustolisi R
Haematologica; 2000 Aug; 85(8):800-5. PubMed ID: 10942925
[TBL] [Abstract][Full Text] [Related]
5. Circulating serum levels of IL-20 in multiple myeloma patients: its significance in angiogenesis and disease activity.
Alexandrakis MG; Pappa CA; Kokonozaki M; Boula A; Vyzoukaki R; Staphylaki D; Papadopoulou A; Androulakis N; Tsirakis G; Sfiridaki A
Med Oncol; 2015 Mar; 32(3):42. PubMed ID: 25631632
[TBL] [Abstract][Full Text] [Related]
6. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
Alexandrakis MG; Passam FH; Boula A; Christophoridou A; Aloizos G; Roussou P; Kyriakou DS
Ann Hematol; 2003 Jan; 82(1):19-23. PubMed ID: 12574959
[TBL] [Abstract][Full Text] [Related]
7. Monitoring serum levels ELR+ CXC chemokines and the relationship between microvessel density and angiogenic growth factors in multiple myeloma.
Pappa CA; Tsirakis G; Kanellou P; Kaparou M; Stratinaki M; Xekalou A; Alegakis A; Boula A; Stathopoulos EN; Alexandrakis MG
Cytokine; 2011 Dec; 56(3):616-20. PubMed ID: 21940178
[TBL] [Abstract][Full Text] [Related]
8. Prognostic impact of angiopoietin-2 in multiple myeloma.
Pappa CA; Alexandrakis MG; Boula A; Thanasia A; Konsolas I; Alegakis A; Tsirakis G
J Cancer Res Clin Oncol; 2014 Oct; 140(10):1801-5. PubMed ID: 24906877
[TBL] [Abstract][Full Text] [Related]
9. Angiopoietin-2 in Bone Marrow milieu promotes Multiple Myeloma-associated angiogenesis.
Belloni D; Marcatti M; Ponzoni M; Ciceri F; Veschini L; Corti A; Caligaris Cappio F; Ferrarini M; Ferrero E
Exp Cell Res; 2015 Jan; 330(1):1-12. PubMed ID: 25447443
[TBL] [Abstract][Full Text] [Related]
10. Significance of Some Proliferation Markers and Some Prognostic Factors in Patients with Multiple Myeloma and their Impact on the Patients' Survival.
Abdelgawad IA; Radwan NH; Shafik RE; Shokralla HA
Asian Pac J Cancer Prev; 2016; 17(5):2389-94. PubMed ID: 27268602
[TBL] [Abstract][Full Text] [Related]
11. The expression of osteopontin and vascular endothelial growth factor in correlation with angiogenesis in monoclonal gammopathy of undetermined significance and multiple myeloma.
Babarović E; Valković T; Budisavljević I; Balen I; Štifter S; Duletić-Načinović A; Lučin K; Jonjić N
Pathol Res Pract; 2016 Jun; 212(6):509-16. PubMed ID: 26997492
[TBL] [Abstract][Full Text] [Related]
12. Potential role of FLT3-ligand in the angiogenic process of multiple myeloma.
Kokonozaki M; Tsirakis G; Devetzoglou M; Kyriakaki S; Antonakis A; Vyzoukaki R; Pappa CA; Tzardi M; Alexandrakis MG
Leuk Res; 2015 Dec; 39(12):1467-72. PubMed ID: 26521986
[TBL] [Abstract][Full Text] [Related]
13. The combination of intermediate doses of thalidomide and dexamethasone reduces bone marrow micro-vessel density but not serum levels of angiogenic cytokines in patients with refractory/relapsed multiple myeloma.
Hatjiharissi E; Terpos E; Papaioannou M; Hatjileontis C; Kaloutsi V; Galaktidou G; Gerotziafas G; Christakis J; Zervas K
Hematol Oncol; 2004 Dec; 22(4):159-68. PubMed ID: 15991268
[TBL] [Abstract][Full Text] [Related]
14. Lack of correlation between angiogenic cytokines and serum insulin-like growth factor-1 in patients with multiple myeloma.
Pappa CA; Tsirakis G; Psarakis FE; Kolovou A; Tsigaridaki M; Stafylaki D; Sfiridaki K; Alexandrakis MG
Med Oncol; 2013 Mar; 30(1):363. PubMed ID: 23266941
[TBL] [Abstract][Full Text] [Related]
15. High density of tryptase-positive mast cells in patients with multiple myeloma: correlation with parameters of disease activity.
Devetzoglou M; Vyzoukaki R; Kokonozaki M; Xekalou A; Pappa CA; Papadopoulou A; Alegakis A; Androulakis N; Alexandrakis MG
Tumour Biol; 2015 Nov; 36(11):8491-7. PubMed ID: 26026586
[TBL] [Abstract][Full Text] [Related]
16. Assessment of proliferating cell nuclear antigen and its relationship with proinflammatory cytokines and parameters of disease activity in multiple myeloma patients.
Tsirakis G; Pappa CA; Kaparou M; Katsomitrou V; Hatzivasili A; Alegakis T; Xekalou A; Stathopoulos EN; Alexandrakis MG
Eur J Histochem; 2011; 55(3):e21. PubMed ID: 22073368
[TBL] [Abstract][Full Text] [Related]
17. Angiogenic activity of mesenchymal stem cells in multiple myeloma.
Wang X; Zhang Z; Yao C
Cancer Invest; 2011 Jan; 29(1):37-41. PubMed ID: 21166497
[TBL] [Abstract][Full Text] [Related]
18. Correlation of Mast Cell Density With Angiogenic Cytokines in Patients With Active Multiple Myeloma.
Vyzoukaki R; Tsirakis G; Pappa CA; Androulakis N; Kokonozaki M; Tzardi M; Alexandrakis MG
Clin Ther; 2016 Feb; 38(2):297-301. PubMed ID: 26740291
[TBL] [Abstract][Full Text] [Related]
19. Serum soluble CD40L concentration depending on the stage of multiple myeloma and its correlation with selected angiogenic cytokines.
Kamińska J; Koper OM; Dymicka-Piekarska V; Motybel-Iwańczuk E; Ołdziej A; Kemona H
Pol Arch Med Wewn; 2016 May; 126(5):321-9. PubMed ID: 27243341
[TBL] [Abstract][Full Text] [Related]
20. Bortezomib mediates antiangiogenesis in multiple myeloma via direct and indirect effects on endothelial cells.
Roccaro AM; Hideshima T; Raje N; Kumar S; Ishitsuka K; Yasui H; Shiraishi N; Ribatti D; Nico B; Vacca A; Dammacco F; Richardson PG; Anderson KC
Cancer Res; 2006 Jan; 66(1):184-91. PubMed ID: 16397231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
